Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 700 of 1,261

  1. US 9308246

    Capsule composition for use as immunogen against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  2. US 9308274

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  3. US 9308211

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  4. US 9308206

    Compositions and methods for treating colon cancer

    The Board of Regents of the University of Texas System · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  5. US 9308176

    Less abusable pharmaceutical preparations

    Supernus Pharmaceuticals, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  6. US 9308163

    Methods of treating and preventing diseases and disorders of the central nervous system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  7. US 9307783

    Drinking water formulation and method and article relating to same

    ESSENTIALIFE HOMEOPATHICS · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  8. US 9309237

    HIV inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  9. US 9309231

    Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  10. US 9309325

    Antibodies and methods of use thereof

    The Regents of the University of California · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  11. US 9308213

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  12. US 9308182

    Parenteral formulations of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  13. US 9309279

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  14. US 9302015

    Anti-PRLR antibodies and methods for killing PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  15. US 9303068

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  16. US 9303044

    7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  17. US 9302013

    Active principle for mitigating undesired medical conditions

    TERMIRA AB · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  18. US 9301940

    Methods for screening antimicrobial and antiviral compounds and uses thereof

    Northwestern University · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  19. US 9301920

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  20. US 9301509

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  21. US 9303045

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  22. US 9301927

    Para-xylene films and therapeutic uses thereof

    Northwestern University · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  23. US 9303053

    Compositions and methods to treat cardiac diseases

    UNIVERSITY OF CONNECTICUT · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  24. US 9303042

    Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.